Circadian Rhythm in Serum Iron Levels

被引:8
作者
Cao, Guo Ying [1 ]
Li, Yang [1 ]
Jin, Peng Fei [1 ]
Hu, Xin [1 ]
机构
[1] Beijing Hosp, Dept Clin Pharmacol, Beijing 100730, Peoples R China
关键词
Iron; Circadian rhythm; Endogenous substance; DIURNAL-VARIATION; FERROUS SULFATE; BIOEQUIVALENCE; ANEMIA;
D O I
10.1007/s12011-011-9304-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study was aimed at assessing the circadian rhythm of serum iron levels in Chinese healthy subjects. The project was conducted in 19 healthy, Chinese male subjects following a 4-day diet equilibration. Blood samples were collected on day 5 at 0800, 1000, 1200, 1400, 1600, 1800, 2000, and 2400 hours to determine endogenous serum iron concentrations. Iron concentrations were determined using an inductively coupled plasma mass spectrometry. Iron concentration was decreased from morning to afternoon. The minimum value of iron level was 1,987 mu g/L at 2000 hours while the maximum was 2,229 mu g/L at 1000 hours, and 2,278 mu g/L at 1400 hours, respectively, the amplitude was 291 mu g/L. This study indicates that when assessing the bioequivalence of iron formulations, baseline levels of iron (obtained before dosing) should not be subtracted simply from the amount obtained on the drug dosing day to yield the net effect of iron formulation administration. More valid methods to optimize the design of such bioequivalence studies should be taken into consideration.
引用
收藏
页码:63 / 66
页数:4
相关论文
共 20 条
  • [1] Treament and prevention of anemia with ferrous sulfate plus folic acid in children attending daycare centers in Goiania, Goias State, Brazil: a randomized controlled trial
    Costa Monteiro Hadler, Maria Claret
    Sigulem, Dirce Maria
    Costa Alves, Maria de Fatima
    Torres, Vinicius Montenegro
    [J]. CADERNOS DE SAUDE PUBLICA, 2008, 24 : S259 - S271
  • [2] COSTONGS GMPJ, 1985, J CLIN CHEM CLIN BIO, V23, P7
  • [3] The effectiveness of three regimens using ferrous sulfate to treat anemia in pregnant women
    de Souza, AI
    Batista, M
    Ferreira, LOC
    Figueirôa, JN
    [J]. REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 15 (05): : 313 - 319
  • [4] Drew P, 2006, OXFORD HBD CLIN HEMA, P40
  • [5] European Agency for the Evaluation of Medicinal Products (EMEA), 2009, INT C HARM WHO GUID
  • [6] HAMILTON LD, 1950, P SOC EXP BIOL MED, V75, P65
  • [7] Bioequivalence between ready-to-use recombinant human growth hormone (rhGH) in liquid formulation and rhGH for reconstitution
    Jacobsen, LV
    Rolan, P
    Christensen, MS
    Knudsen, KM
    Rasmussen, MH
    [J]. GROWTH HORMONE & IGF RESEARCH, 2000, 10 (02) : 93 - 98
  • [8] LIU JQ, 2005, MED J W CHINA, V17, P24
  • [9] LONG R, 1978, CLIN CHEM, V24, P842
  • [10] Bioequivalence of liquid and freeze-dried recombinant human follicle-stimulating hormone
    Lugan, I
    Febbraro, S
    Lecuelle, H
    Papasouliotis, O
    Ho-Nguyen, Q
    Buraglio, M
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (01) : 121 - 125